<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>12583</id><no>AREN1921-NCT04322318</no><status>Open</status><title>Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors(DAWT)and Relapsed Favorable Histology Wilms Tumors(FHWT)</title><secondary_protocol_no>AREN1921</secondary_protocol_no><nct_id>NCT04322318</nct_id><sponsor_type>National</sponsor_type><age_group>Both</age_group><treatment_type>Treatment</treatment_type><phase>II (Cancer Control)</phase><cancer_control>Y</cancer_control><scope>National</scope><disease_site>Kidney</disease_site><PI>Pudela, Caileigh</PI><oncology_group>Pediatrics<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC)</management_group></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>